IEC Residents Meeting

Saturday, October 23, 2021 | 9:00 am - 4:30 pm EDT
Advanced Topics in Atopic Dermatitis
Inaugural Dermatology Residents Virtual Meeting

International Eczema Council presents a comprehensive program on the diagnosis, treatment, pathophysiology, and comorbidities, related to the management of Atopic Dermatitis (AD).

Open to all dermatology residents and fellows, the program will feature didactic lecture and interactive discussion.  A certificate of completion will be provided to attendees that complete the entire program.

This one-day session features international experts in Atopic Dermatitis and will focus on newly-emerging clinically applicable knowledge — ranging from new guidelines to recognition of emerging agents and adverse events to translational research. 

This program is supported in part by an educational grant from Cara Therapeutics.

Program Chairs

Robert Bissonnette, IEC President
Robert Bissonnette, MD FRCPC, is Board certified in dermatology and the president of Innovaderm Research—a contract research organization (CRO) specializing in the design, conduct, and analysis of clinical trials in various areas of dermatology—in Montreal, QC, Canada.

 

  

 

Emma Guttman, IEC Immediate Past-President
Emma Guttman, MD PhD, is the Health System Chair, Waldman Professor and System Chair, Dermatology and Immunology, Director, Center of Excellence for Eczema and the Occupational Dermatitis Clinic, and Director, Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA
 

Sessions will include: 

  • Atopic Dermatitis: The Tale of a Success Story | Emma Guttman, MD, PhD. | New York, NY, USA
  • The Barrier abnormalities of AD and potential for prevention strategies | Alan Irvine, MD, DSc, Professor of Dermatology, Trinity College Dublin, Children’s Health, Dublin, Ireland
  • The neuropsychiatric comorbidities of AD and personal and familial burden of disease | Mike Cork, BSc, MB, PhD, FRCP | Sheffield Dermatology Research, The University of Sheffield Medical School, Sheffield, UK
  • Existing and Novel Topical Treatments for AD | Robert Bissonnette, MD, FRCPC, MSc | Montreal, QC, Canada
  • Current and New Systemic Treatments | Eric Simpson, MD, MCR | School of Medicine, Oregon Health & Science University, Portland, Oregon, USA
  • Ocular Manifestations of AD | Marjolein De Bruin-Weller, MD, PhD | University Medical Center Utrecht, Netherlands
  • Pediatric Atopic Dermatitis: Children are more than little adults | Amy Paller, MD, MS | Northwestern University Feinberg School of Medicine, Chicago, IL, USA
  • Epithelial Barrier Hypothesis for the Development of Allergic and Autoimmune Diseases  | Cezmi Akdis, MD | Allergy Journal, Editor in Chief, University of Zurich
  • Emerging Global and US Epidemiologic Trends in AD | Jonathan Silverberg, MD, MPH, PhD | The George Washington University School of Medicine and Health Sciences, Washington, D.C., USA
  • Comorbidities of AD and their Pathogenesis  | Aaron Drucker, MD, ScM, FRCPC | University of Toronto, Toronto, Ontario, Canada

 

Meeting registration is now closed. The event is being recorded and will be available soon on-demand. Please check back soon.

 

Download Event Flyer